...
首页> 外文期刊>Journal of Economic Entomology >Evaluation of lysozyme-HCl for the treatment of chalkbrood disease in honey bee colonies
【24h】

Evaluation of lysozyme-HCl for the treatment of chalkbrood disease in honey bee colonies

机译:盐酸溶菌酶治疗蜂群白垩病的效果评估

获取原文
获取原文并翻译 | 示例
           

摘要

Chalkbrood, caused by Ascosphaera apis (Maassen and Claussen) Olive and Spiltor, is a cosmopolitan fungal disease of honey bee larvae (Apis mellifera L.) for which there is no chemotherapeutic control. We evaluated the efficacy of lysozyme-HCl, an inexpensive food-grade antimicrobial extracted from hen egg white, for the treatment of chalkbrood disease in honey bee colonies. Our study compared three doses of lysozyme-HCl in sugar syrup (600, 3,000, and 6,000 mg) administered weekly for 3 wk among chalkbrood-inoculated colonies, colonies that were inoculated but remained untreated, and colonies neither inoculated or treated. Lysozyme-HCl at the highest dose evaluated was found to suppress development of chalkbrood disease in inoculated colonies to levels observed in uninoculated, untreated colonies, and did not adversely affect adult bee survival or brood production. Honey production was significantly negatively correlated with increased disease severity but there were no significant differences in winter survival among treatment groups. Based on our results, lysozyme-HCl appears to be a promising, safe therapeutic agent for the control of chalkbrood in honey bee colonies.
机译:由Ascosphaera apis(Maassen和Claussen)Olive和Spiltor引起的Chalkbrood是蜜蜂幼虫(Apis mellifera L.)的一种国际性真菌病,无法对其进行化学治疗控制。我们评估了溶菌酶-HCl(一种从母鸡蛋白中提取的廉价食品级抗菌剂)在蜜蜂群体中治疗白垩病的功效。我们的研究比较了在白垩病接种的菌落,接种但未治疗的菌落以及未接种或未治疗的菌落中每周3周每周施用的糖浆(600、3,000和6,000 mg)中的三剂溶菌酶-HCl。发现最高评估剂量的溶菌酶-HCl可将接种菌落中白垩病的发生抑制到未接种,未处理菌落中观察到的水平,并且不会对成年蜜蜂的存活或繁殖产生不利影响。蜂蜜产量与疾病严重程度显着负相关,但各治疗组之间的冬季存活率无显着差异。根据我们的结果,溶菌酶-HCl似乎是一种有前途的,安全的控制蜜蜂群体白垩病的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号